UBS’s CAS Medical Systems, Inc. CASM Stock Holding History

UBS’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-627	Closed	-$1K	–	11036
2014 Q1	$1K	Sell	627 -2,489	-80%	-$5.29K	﹤0.01%	10264
2013 Q4	$5K	Sell	3,116 -323,410	-99%	-$505K	﹤0.01%	9610
2013 Q3	$438K	Sell	326,526 -5,303	-2%	-$7.79K	﹤0.01%	4283
2013 Q2	$554K	Buy	+331,829	New	+$614K	﹤0.01%	3999

Other funds holding CASM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BMI Capital New York $49.9M AUM 8.11% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1CM

1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

UBS's CASM Position: Q2 2014 in Review

UBS sold out of CAS Medical Systems, Inc. (CASM) in Q2 2014, closing a stake of 627 shares — an estimated $1K sold.

UBS first reported a position in CASM in Q2 2013 and held it in 4 quarters. The position peaked at $554K in Q2 2013. 23 funds tracked by Wall St. Rank hold CASM as of Q2 2014.

UBS reported no remaining CAS Medical Systems, Inc. position as of Q2 2014 after selling out during the quarter.
UBS sold 627 CAS Medical Systems, Inc. shares in Q2 2014, an estimated $1K.
UBS first reported a position in CAS Medical Systems, Inc. in Q2 2013 and held it in 4 quarters.
UBS's CAS Medical Systems, Inc. position peaked at $554K in Q2 2013.
23 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.